Diagnostic Value of Adenosine Deaminase and Its Isoforms in Type II Diabetes Mellitus.

IF 2.5 3区物理与天体物理 Q2 OPTICS Optics Communications Pub Date : 2016-01-01 Epub Date: 2016-12-05 DOI:10.1155/2016/9526593

Bagher Larijani, Ramin Heshmat, Mina Ebrahimi-Rad, Shohreh Khatami, Shirin Valadbeigi, Reza Saghiri

{"title":"Diagnostic Value of Adenosine Deaminase and Its Isoforms in Type II Diabetes Mellitus.","authors":"Bagher Larijani, Ramin Heshmat, Mina Ebrahimi-Rad, Shohreh Khatami, Shirin Valadbeigi, Reza Saghiri","doi":"10.1155/2016/9526593","DOIUrl":null,"url":null,"abstract":"Background and Aims. In the present study, we have investigated the activity of adenosine deaminase (ADA) as a diagnostic marker in type 2 (or II) diabetes mellitus (T2DM). Design and Methods. The deaminase activity of ADA1 and ADA2 was determined in serum from 33 patients with type 2 (or II) diabetes mellitus and 35 healthy controls. We also determined the proportion of glycated hemoglobin (HbA1c). Results. Our results showed significant differences between total serum ADA (tADA) and ADA2 activities in the diabetic groups with HbA1c < 8 (%) and HbA1c ≥ 8 (%) with respect to the values in healthy individuals (p < 0.001). ADA2 activity in patients with high HbA1c was found to be much higher than that in patients with low HbA1c (p = 0.0001). In addition, total ADA activity showed a significant correlation with HbA1c (r = 0.6, p < 0.0001). Conclusions. Total serum ADA activity, specially that due to ADA2, could be useful test for the diagnosis of type 2 (or II) diabetes mellitus.","PeriodicalId":19586,"journal":{"name":"Optics Communications","volume":"2 1","pages":"9526593"},"PeriodicalIF":2.5000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5165159/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Optics Communications","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2016/9526593","RegionNum":3,"RegionCategory":"物理与天体物理","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2016/12/5 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"OPTICS","Score":null,"Total":0}

引用次数: 0

Abstract

Background and Aims. In the present study, we have investigated the activity of adenosine deaminase (ADA) as a diagnostic marker in type 2 (or II) diabetes mellitus (T2DM). Design and Methods. The deaminase activity of ADA1 and ADA2 was determined in serum from 33 patients with type 2 (or II) diabetes mellitus and 35 healthy controls. We also determined the proportion of glycated hemoglobin (HbA1c). Results. Our results showed significant differences between total serum ADA (tADA) and ADA2 activities in the diabetic groups with HbA1c < 8 (%) and HbA1c ≥ 8 (%) with respect to the values in healthy individuals (p < 0.001). ADA2 activity in patients with high HbA1c was found to be much higher than that in patients with low HbA1c (p = 0.0001). In addition, total ADA activity showed a significant correlation with HbA1c (r = 0.6, p < 0.0001). Conclusions. Total serum ADA activity, specially that due to ADA2, could be useful test for the diagnosis of type 2 (or II) diabetes mellitus.

Abstract Image

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

腺苷脱氨酶及其同工酶对 II 型糖尿病的诊断价值

背景和目的：在本研究中，我们探讨了作为 2 型（或 II 型）糖尿病（T2DM）诊断指标的腺苷脱氨酶（ADA）活性。设计与方法。我们测定了 33 名 2 型（或 II 型）糖尿病患者和 35 名健康对照者血清中 ADA1 和 ADA2 的脱氨酶活性。我们还测定了糖化血红蛋白（HbA1c）的比例。结果显示我们的结果显示，HbA1c < 8 (%) 和 HbA1c ≥ 8 (%) 的糖尿病组血清总 ADA (tADA) 和 ADA2 活性与健康人的值有明显差异（p < 0.001）。高 HbA1c 患者的 ADA2 活性远高于低 HbA1c 患者（p = 0.0001）。此外，总 ADA 活性与 HbA1c 呈显著相关性（r = 0.6，p < 0.0001）。结论血清总 ADA 活性，尤其是 ADA2 活性，可作为诊断 2 型（或 II 型）糖尿病的有用检测指标。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Optics Communications 物理-光学

CiteScore

5.10

自引率

8.30%

发文量

681

审稿时长

38 days

期刊介绍： Optics Communications invites original and timely contributions containing new results in various fields of optics and photonics. The journal considers theoretical and experimental research in areas ranging from the fundamental properties of light to technological applications. Topics covered include classical and quantum optics, optical physics and light-matter interactions, lasers, imaging, guided-wave optics and optical information processing. Manuscripts should offer clear evidence of novelty and significance. Papers concentrating on mathematical and computational issues, with limited connection to optics, are not suitable for publication in the Journal. Similarly, small technical advances, or papers concerned only with engineering applications or issues of materials science fall outside the journal scope.